Overactivation of PERK-Mediated Endoplasmic Reticulum Stress-Induced Testis Damage in Chronically Stressed Mice

PERK介导的内质网应激过度激活诱导慢性应激小鼠睾丸损伤

阅读:1

Abstract

INTRODUCTION: Although endoplasmic reticulum stress (ERS) is known to be associated with spermatogenesis, there is limited information about the role and impact of ERS on chronic stress-induced male infertility. METHODS: To determine the alteration in ERS-related proteins after chronic restraint stress (CRS), these male C57BL/6J mice were randomly divided into the control or CRS group. An ERS inhibitor, integrated stress response inhibitor (ISRIB), was used to establish the causal relationship between ERS and CRS-induced testicular damage, for which male C57BL/6J mice were randomly divided into the following three groups: normal + normal saline (NS), CRS + NS, and CRS + ISRIB. The ERS pathway-related proteins, sperm parameters, testicular structure, spermatogenic cell markers, enzymes involved in steroid biosynthesis, serum corticosterone (CORT) and gonadotropin-releasing hormone (GnRH) levels, and c-fos expression in the hypothalamic paraventricular nucleus (PVN) were evaluated. RESULTS: CRS primarily activated the pancreatic endoplasmic reticulum kinase (PERK)-mediated ERS pathway in the testis. ISRIB administration improved histology structure, low semen quality, expression of spermatogenic cell markers, and the level of enzymes related to steroid biosynthesis in CRS mice. ISRIB administration also reduced serum CORT levels and normalized hypothalamic PVN neuronal activation, accompanied by increased serum GnRH levels in CRS mice. CONCLUSIONS: CRS increased p-PERK expression in the testis. However, treatment with the PERK blocker ISRIB improved sperm quality, preserved testis structure, and rescued the expression of steroidogenesis genes in CRS mice, which might be due to the restoration of the hypothalamic-pituitary-adrenal axis and hypothalamic-pituitary-gonadal function.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。